#Clinical Trials #Belgium #One2Treat #Patient Voice #Louvain-la-Neuve

One2Treat Launches One2Treat Voice App

In a groundbreaking move, One2Treat SA, a prominent tech firm dedicated to amplifying the patient voice in clinical development, has unveiled its latest innovation: the One2Treat Voice app. This cutting-edge tool is part of a larger software platform aimed at redefining treatment assessment in pharmaceutical research and development (R&D).

Enhancing Patient Engagement in Clinical Trials

The One2Treat Voice app epitomizes the company’s commitment to integrating patient insights into every stage of clinical trials. With this new feature, sponsors of clinical trials can align their goals with what truly matters to patients and clinicians alike. By focusing on patient and clinician perspectives, One2Treat Voice helps in the identification and prioritization of critical clinical outcomes that guide endpoint selection.

According to Marc Buyse, the founder of One2Treat, “The past year has reinforced the importance of aligning patient-centricity with scientific rigor. Our efforts, alongside the release of One2Treat Voice, are set to enhance the relevance and transparency of clinical developments for patients, clinicians, regulators, and pharmaceutical sponsors.”

Data-Driven Approach to Clinical Outcomes

One2Treat Voice introduces a sophisticated system designed to systematically gather insights from various stakeholders — including patients, clinicians, regulatory bodies, and clinical trial sponsors. By utilizing a structured, data-driven process, this app allows for the definition of multi-dimensional primary endpoints through the Net Treatment Benefit (NTB) methodology.

Pascal Piedbois, the Chief Medical Officer at One2Treat, stated, “By embedding diverse stakeholder voices early in the protocol development process, One2Treat Voice helps sponsors craft trials that are not only scientifically sound but also reflective of the values and expectations of the clinical development community. This approach can often result in substantial sample size reductions.”

A Comprehensive Cloud-Based Platform

The One2Treat Voice app is a key component of a broader cloud-based platform that aims to facilitate strategic decision-making throughout the clinical development life cycle—from initial protocol design to in-depth data analysis. This platform empowers sponsors to evaluate the totality of evidence available and assess a treatment’s overall medical value.

The One2Treat software is designed to support a variety of decision-making processes, such as trial design, go/no-go evaluations, dosing strategies, market access planning, and commercialization, all based on outcomes prioritized by both patients and clinicians.

Sébastien Coppe, the CEO of One2Treat, emphasized, “One2Treat Voice harmonizes quantitative and qualitative methods to gather and prioritize patient preferences. Our collaboration with pharma sponsors and input from patient advocates, site investigators, and regulatory authorities underscore our commitment to fostering a patient-focused drug development process that emphasizes meaningful treatment evaluation.”

About One2Treat

Established as a fast-expanding tech entity, One2Treat is dedicated to weaving the patient voice into all significant treatment assessment decisions within the realm of pharmaceutical R&D. The company strives to revolutionize how biopharmaceutical organizations design and assess clinical trials by infusing various meaningful dimensions into treatment evaluations.

For further details regarding One2Treat and their innovative approach to clinical development and market access, please visit www.one2treat.com.